Controlled release formulations of Ranitidine

Details Controlled release formulations of Ranitidine Controlled release formulations of Ranitidine

1995-09-01

1998-12-29

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424452, 424457, 424458, 424461, 424462, 424468, 424469, 424470, A61K 926, A61K 958, A61K 962

Patent

active

058537562

ABSTRACT:
The present invention provides oral formulations of Ranitidine Hydrochloride in the form of coated tablets and capsules which produce controlled or regulated dissolution and release at a fairly uniform rate over long periods--as long as 12 to 24 hours--to maintain Ranitidine at desired levels above the MEC.

REFERENCES:
patent: 5407687 (1995-04-01), Coffin et al.
patent: 5578316 (1996-11-01), Bhardwaj et al.

Affiliated with

Also associated with

Rating

Controlled release formulations of Ranitidine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release formulations of Ranitidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulations of Ranitidine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1422031